[24 October 2013]
Products Affected - Description
Azithromycin injection - Apotex
500 mg vial, package of 10 (NDC 60505-6076-04)
Reason for the Shortage
- Apotex could not provide a reason for the shortage.
- Pfizer discontinued Zithromax 500 mg vial with Vial-Mate Adaptor in January 2013.
Azithromycin injection, APP
500 mg vial, package of 10 (NDC 63323-0398-10)
500 mg Novaplus vial, package of 10 (NDC 63323-0398-12)
Azithromycin injection, Hospira
500 mg ADD-vantage vial, package of 10 (NDC 00409-0144-11)
Zithromax injection - Pfizer
500 mg vial, package of 10 (NDC 00069-3150-83)
Azithromycin injection - Sagent
500 mg vial, package of 10 (NDC 25021-0112-10)
Estimated Resupply Dates
Apotex has azithromycin injection 500 mg vials on allocation.
October 24, 2013; September 23, 2013; August 13, 2013; July 29, 2013; July 2, 2013; June 24, 2013; June 4, 2013; May 24, 2013; May 3, 2013; April 17, 2013; April 3, 2013; March 29, 2013; March 11, 2013; February 6, 2013; January 29, 2013; January 23, 2013; January 10, 2013; January 9, 2013; January 2, 2013; University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins